Literature DB >> 23123293

Mechanism of oral tolerance induction to therapeutic proteins.

Xiaomei Wang1, Alexandra Sherman, Gongxian Liao, Kam W Leong, Henry Daniell, Cox Terhorst, Roland W Herzog.   

Abstract

Oral tolerance is defined as the specific suppression of humoral and/or cellular immune responses to an antigen by administration of the same antigen through the oral route. Due to its absence of toxicity, easy administration, and antigen specificity, oral tolerance is a very attractive approach to prevent unwanted immune responses that cause a variety of diseases or that complicate treatment of a disease. Many researchers have induced oral tolerance to efficiently treat autoimmune and inflammatory diseases in different animal models. However, clinical trials yielded limited success. Thus, understanding the mechanisms of oral tolerance induction to therapeutic proteins is critical for paving the way for clinical development of oral tolerance protocols. This review will summarize progress on understanding the major underlying tolerance mechanisms and contributors, including antigen presenting cells, regulatory T cells, cytokines, and signaling pathways. Potential applications, examples for therapeutic proteins and disease targets, and recent developments in delivery methods are discussed.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23123293      PMCID: PMC3578149          DOI: 10.1016/j.addr.2012.10.013

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  206 in total

1.  T-cell activation occurs simultaneously in local and peripheral lymphoid tissue following oral administration of a range of doses of immunogenic or tolerogenic antigen although tolerized T cells display a defect in cell division.

Authors:  Karen M Smith; Joanne M Davidson; Paul Garside
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

Review 2.  New trends in antigen uptake in the gut mucosa.

Authors:  Florence Niedergang; Mi-Na Kweon
Journal:  Trends Microbiol       Date:  2005-10       Impact factor: 17.079

3.  Induction of colonic regulatory T cells by indigenous Clostridium species.

Authors:  Koji Atarashi; Takeshi Tanoue; Tatsuichiro Shima; Akemi Imaoka; Tomomi Kuwahara; Yoshika Momose; Genhong Cheng; Sho Yamasaki; Takashi Saito; Yusuke Ohba; Tadatsugu Taniguchi; Kiyoshi Takeda; Shohei Hori; Ivaylo I Ivanov; Yoshinori Umesaki; Kikuji Itoh; Kenya Honda
Journal:  Science       Date:  2010-12-23       Impact factor: 47.728

4.  Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

Authors:  L Chaillous; H Lefèvre; C Thivolet; C Boitard; N Lahlou; C Atlan-Gepner; B Bouhanick; A Mogenet; M Nicolino; J C Carel; P Lecomte; R Maréchaud; P Bougnères; B Charbonnel; P Saï
Journal:  Lancet       Date:  2000-08-12       Impact factor: 79.321

5.  Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.

Authors:  Jun Shimizu; Sayuri Yamazaki; Takeshi Takahashi; Yasumasa Ishida; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

Review 6.  Factor VIII inhibitors. Potential for prevention of inhibitor formation by immune tolerance.

Authors:  J Kaplan; C Genyea; E Secord
Journal:  Semin Thromb Hemost       Date:  2000       Impact factor: 4.180

7.  Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance.

Authors:  Wan-Uk Kim; Woo-Kyoung Lee; Jae-Woong Ryoo; Seung-Hoon Kim; Jin Kim; Jeehee Youn; So-Youn Min; Eui-Young Bae; Sue-Yun Hwang; Sung-Hwan Park; Chul-Soo Cho; Jong-Sang Park; Ho-Youn Kim
Journal:  Arthritis Rheum       Date:  2002-04

8.  Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches.

Authors:  Thomas W Spahn; Howard L Weiner; Paul D Rennert; Norbert Lügering; Adriano Fontana; Wolfram Domschke; Torsten Kucharzik
Journal:  Eur J Immunol       Date:  2002-04       Impact factor: 5.532

9.  The interrelated roles of TGF-beta and IL-10 in the regulation of experimental colitis.

Authors:  Ivan J Fuss; Monica Boirivant; Brian Lacy; Warren Strober
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

10.  The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease.

Authors:  M F Neurath; B Weigmann; S Finotto; J Glickman; E Nieuwenhuis; H Iijima; A Mizoguchi; E Mizoguchi; J Mudter; P R Galle; A Bhan; F Autschbach; B M Sullivan; S J Szabo; L H Glimcher; R S Blumberg
Journal:  J Exp Med       Date:  2002-05-06       Impact factor: 14.307

View more
  36 in total

1.  Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector.

Authors:  Romain Hardet; Benjamin Chevalier; Léa Dupaty; Yassine Naïmi; Gaëtan Riou; Laurent Drouot; Laetitia Jean; Anna Salvetti; Olivier Boyer; Sahil Adriouch
Journal:  Mol Ther       Date:  2015-08-12       Impact factor: 11.454

Review 2.  T cells in the control of organ-specific autoimmunity.

Authors:  Jeffrey A Bluestone; Hélène Bour-Jordan; Mickie Cheng; Mark Anderson
Journal:  J Clin Invest       Date:  2015-05-18       Impact factor: 14.808

Review 3.  From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Authors:  Natalie L Trevaskis; Lisa M Kaminskas; Christopher J H Porter
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

Review 4.  Edible plants for oral delivery of biopharmaceuticals.

Authors:  Matilde Merlin; Mario Pezzotti; Linda Avesani
Journal:  Br J Clin Pharmacol       Date:  2016-05-09       Impact factor: 4.335

5.  Buttermilk: an important source of lipid soluble forms of choline that influences the immune system development in Sprague-Dawley rat offspring.

Authors:  Jessy Azarcoya-Barrera; Catherine J Field; Susan Goruk; Alexander Makarowski; Jonathan M Curtis; Yves Pouliot; René L Jacobs; Caroline Richard
Journal:  Eur J Nutr       Date:  2021-01-08       Impact factor: 5.614

Review 6.  Vaccination via Chloroplast Genetics: Affordable Protein Drugs for the Prevention and Treatment of Inherited or Infectious Human Diseases.

Authors:  Henry Daniell; Hui-Ting Chan; Elise K Pasoreck
Journal:  Annu Rev Genet       Date:  2016-10-21       Impact factor: 16.830

7.  Oral immunotherapy tolerizes mice to enzyme replacement therapy for Morquio A syndrome.

Authors:  Angela C Sosa; Barbara Kariuki; Qi Gan; Alan P Knutsen; Clifford J Bellone; Miguel A Guzmán; Luis A Barrera; Shunji Tomatsu; Anil K Chauhan; Eric Armbrecht; Adriana M Montaño
Journal:  J Clin Invest       Date:  2020-03-02       Impact factor: 14.808

8.  Oral delivery of Acid Alpha Glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of Pompe mice.

Authors:  Jin Su; Alexandra Sherman; Phillip A Doerfler; Barry J Byrne; Roland W Herzog; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2015-06-05       Impact factor: 9.803

Review 9.  Plant-made oral vaccines against human infectious diseases-Are we there yet?

Authors:  Hui-Ting Chan; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2015-09-07       Impact factor: 9.803

10.  Oral delivery of bioencapsulated proteins across blood-brain and blood-retinal barriers.

Authors:  Neha Kohli; Donevan R Westerveld; Alexandra C Ayache; Amrisha Verma; Pollob Shil; Tuhina Prasad; Ping Zhu; Sic L Chan; Qiuhong Li; Henry Daniell
Journal:  Mol Ther       Date:  2013-12-06       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.